Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recurrent idiopathic hepatitis: a new entity?

Jason R Phillips¹, Paul Angulo, Keith Lindor

¹Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Journal of Clinical Gastroenterology

|September 10, 2003

Summary

This summary is machine-generated.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis.

JHEP reports : innovation in hepatology·2024

Same author

Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

Hepatology (Baltimore, Md.)·2024

Same author

The power of rotation schedules on the career selection decisions of medical students.

Advances in health sciences education : theory and practice·2023

Same author

Machine learning in primary biliary cholangitis: A novel approach for risk stratification.

Liver international : official journal of the International Association for the Study of the Liver·2021

Same author

Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.

Digestive diseases and sciences·2021

Same author

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.

Hepatology international·2021

Same journal

GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

Journal of clinical gastroenterology·2026

Same journal

Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

Journal of clinical gastroenterology·2026

Same journal

International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026

Same journal

Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

Journal of clinical gastroenterology·2026

Same journal

Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

Journal of clinical gastroenterology·2026

Same journal

The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

Journal of clinical gastroenterology·2026

See all related articles

A new clinical condition, recurrent idiopathic hepatitis, is described. This entity may be similar to recurrent idiopathic cholestasis.

Area of Science:

Hepatology
Clinical Medicine
Gastroenterology

Background:

Idiopathic liver diseases present diagnostic challenges.
Recurrent cholestasis is a recognized clinical entity.

Observation:

A case report details a novel clinical presentation.
The patient experienced recurrent episodes suggestive of liver inflammation.

Findings:

A new clinical entity, recurrent idiopathic hepatitis, is proposed.
This condition shares similarities with recurrent idiopathic cholestasis.

Implications:

Recognition of recurrent idiopathic hepatitis may improve diagnosis.
Further research is needed to understand its pathogenesis and treatment.